Items where authors include "Hyrich, KL"

Article

Curry, PDK, Chinoy, H, Jani, M et al. (8 more authors) (2023) The impact of COVID-19 on medication adherence in a rheumatoid (BRAGGSS) and psoriatic arthritis (OUTPASS) UK cohort. The Journal of Rheumatology, 50 (7). jrheum.2022-1277. ISSN 0315-162X

Hum, RM, Ho, P, Nair, N et al. (8 more authors) (2023) Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. Rheumatology, 62 (6). pp. 2090-2097. ISSN 1462-0324

Smith, SL, Alexander, S, Nair, N et al. (8 more authors) (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Sutcliffe, M, Nair, N, Oliver, J et al. (9 more authors) (2022) Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy. Rheumatology, 61 (12). pp. 4935-4944. ISSN 1462-0324

Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Oliver, J, Nair, N, Orozco, G et al. (7 more authors) (2021) Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment. Arthritis Research & Therapy, 23 (1). 139. ISSN 1478-6354

Oliver, J, Nair, N, Orozco, G et al. (8 more authors) (2021) Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment. Arthritis Research & Therapy, 23 (1). 80. ISSN 1478-6354

Dagliati, A, Plant, D, Nair, N et al. (10 more authors) (2020) Latent class trajectory modelling of 2‐components‐DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti‐rheumatic drugs. Arthritis & Rheumatology, 72 (10). pp. 1632-1642. ISSN 2326-5191

Nair, N, Plant, D, Verstappen, SM et al. (6 more authors) (2020) Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis. Rheumatology, 59 (6). pp. 1364-1371. ISSN 1462-0324

Melville, AR, Kearsley-Fleet, L, Buch, MH orcid.org/0000-0002-8962-5642 et al. (1 more author) (2020) Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach. Drugs, 80 (9). pp. 849-857. ISSN 0012-6667

Pan, Y, Norton, S, Gwinnutt, JM et al. (7 more authors) (2019) Not all moderate disease is the same – Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity. PLOS ONE, 14 (5). e0215999. ISSN 1932-6203

Kearsley-Fleet, L, Davies, R, De Cock, D et al. (6 more authors) (2018) Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 77 (10). pp. 1405-1412. ISSN 0003-4967

Oldroyd, AGS, Symmons, DPM, Sergeant, JC et al. (35 more authors) (2018) Long-term persistence with rituximab in patients with rheumatoid arthritis. Rheumatology, 57 (6). pp. 1089-1096. ISSN 1462-0324

Nikiphorou, E, Buch, MH orcid.org/0000-0002-8962-5642 and Hyrich, KL (2017) Biologics registers in RA: methodological aspects, current role and future applications. Nature Reviews Rheumatology, 13 (8). pp. 503-510. ISSN 1759-4790

Low, ASL, Symmons, DPM, Lunt, M et al. (5 more authors) (2017) Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 76 (4). pp. 654-660. ISSN 0003-4967

Jani, M, Dixon, WG, Kersley-Fleet, L et al. (7 more authors) (2017) Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open, 3 (1). e000314. ISSN 2056-5933

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2016) Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. Rheumatology, 55 (11). pp. 2050-2055. ISSN 1462-0324

Silva-Fernández, L, Lunt, M, Kearsley-Fleet, L et al. (5 more authors) (2016) The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis. Rheumatology, 55 (11). pp. 2033-2039. ISSN 1462-0324

Plant, D, Webster, A, Nair, N et al. (9 more authors) (2016) Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis. Arthritis and Rheumatology, 68 (6). pp. 1353-1360. ISSN 2326-5191

Bluett, J, Morgan, C, Thurston, L et al. (7 more authors) (2015) Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Rheumatology, 54 (3). pp. 494-499. ISSN 1462-0324

Bluett, J, Ibrahim, I, Plant, D et al. (6 more authors) (2014) Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Pharmacogenomics Journal, 14 (2). pp. 171-175. ISSN 1470-269X

Plant, D, Ibrahim, I, Lunt, M et al. (8 more authors) (2012) Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Research and Therapy, 14 (5). R214. ISSN 1478-6354

Lord, PA, Farragher, TM, Lunt, M et al. (4 more authors) (2010) Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register. Rheumatology, 49 (3). 563 - 570. ISSN 1462-0324